Answers are grounded in this paper and cite their sources.
Cross-sectional study reveals high methicillin-resistant Staphylococcus aureus colonisation in people living with HIV, indicating the need for multisite screening beyond nasal swabs.
Methicillin-resistant Staphylococcus aureus (MRSA) poses a growing threat among people living with HIV/AIDS (PLWH) due to immunological vulnerability, frequent healthcare exposure, and compromised skin integrity. Despite a high HIV burden in Edo State, Nigeria, no data characterising MRSA colonisation in PLWH exist in the State. This study characterised MRSA colonisation among HIV/AIDS Clients of Irrua Specialist Teaching Hospital (ISTH). This is a cross-sectional hospital-based study, with 176 PLWH on ART for ≥6 months systematically enrolled. Three rayon swabs per participant were collected from the nasal vestibule, axillary fold, and groin. MRSA was confirmed by cefoxitin disc diffusion per Clinical Laboratory Standard Institute guidelines. Frequencies, proportions, chi-square, Fisher's exact test, and Kruskal-Wallis H were applied. Significance was set at p<0.05. Of 176 participants, 131 (74.43%) were MRSA-positive, yielding 230 isolates from 528 specimens (43.6% specimen-level positivity). Females predominates, constituted 75.0% (n=132) with overall mean age of 41.78±12.9 years. Majority were married (71.0%), had secondary education (51.1%), and were unskilled workers (65.3%). The groin yielded highest MRSA-positive swabs (94/176, 53.4%), followed by nasal (71/176, 40.3%) and axillary (65/176, 36.9%). MRSA carriage was significantly associated with age group (χ 2 =9.900, p=0.042), occupation (χ 2 =7.173, p=0.047), WHO clinical stage (χ 2 =3.663, p=0.040), and CD4 count category (χ 2 =3.824, p=0.047). The median CD4+ count was 425 cells/µL; participants with CD4 <200 had the highest MRSA positivity (86.5%). MRSA colonisation was high among PLWH at ISTH. The groin-predominant distribution challenges conventional nasal-centric screening paradigms. CD4-stratified MRSA rates and WHO stage associations indicate that immunosuppression contributes to MRSA carriage, supporting targeted screening of the most immunocompromised PLWH.
No takes yet. Share an insight, caveat, or question.
Joan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: